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Background: During ageing an altered redox balance has been observed in both intracellular and extracellular
compartments, primarily due to glutathione depletion and metabolic stress. Maintaining redox homeostasis is
important for controlling proliferation and apoptosis in response to specific stimuli for a variety of cells. For T cells,
the ability to generate specific response to antigen is dependent on the oxidation state of cell surface and
cytoplasmic protein-thiols. Intracellular thiols are maintained in their reduced state by a network of redox regulating
peptides, proteins and enzymes such as glutathione, thioredoxins and thioredoxin reductase. Here we have
investigated whether any relationship exists between age and secreted or cell surface thioredoxin-1, intracellular
glutathione concentration and T cell surface thioredoxin 1 (Trx-1) and how this is related to interleukin (IL)-2
production.
Results: Healthy older adults have reduced lymphocyte surface expression and lower circulating plasma Trx-1
concentrations. Using buthionine sulfoximine to deplete intracellular glutathione in Jurkat T cells we show that cell
surface Trx-1 is lowered, secretion of Trx-1 is decreased and the response to the lectin phytohaemagglutinin
measured as IL-2 production is also affected. These effects are recapitulated by another glutathione depleting
agent, diethylmaleate.
Conclusion: Together these data suggest that a relationship exists between the intracellular redox compartment
and Trx-1 proteins. Loss of lymphocyte surface Trx-1 may be a useful biomarker of healthy ageing.
Keywords: Reduced glutathione, Redox, Cysteine, Ageing, Membrane protein, Thioredoxin-1Background
During ageing, there is a progressive decline the ratio of
cysteine to cystine and reduced to oxidised glutathione
in the plasma which has been attributed to excessive
oxidants within a proinflammatory environment [1].
While such changes can be accompanied by an increase
in oxidatively damaged molecules, it is likely that oxida-
tive damage accumulation during ageing may be more of
a bystander effect than an ageing mechanism as recent
studies have shown that manipulating the levels of many
antioxidant genes and consequently the extent of mo-
lecular damage in a number of species does not inhibit
the ageing process [2].* Correspondence: h.r.griffiths@aston.ac.uk
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distribution, and reproduction in any mediumSeveral physiological systems including cells of the im-
mune system also lose their homeostatic capacity with age
[3,4]. Adaptation is a key process for the acquired immune
system in order for novel antigens to be recognised and
specific response developed. Recent studies have impli-
cated a cooperative interaction between the intracellular
T cell redox environment and exofacial membrane pro-
teins, which ultimately influences T cell function in health
and disease [5,6].
Cellular redox balance is achieved via three major
redox couples; NAD-NADH; NADP-NADPH and the
cysteine containing tripeptide, glutathione (GSH) -
oxidised glutathione (GSSG) [7]. Cellular GSH concen-
tration is dependent on the activity of gamma-glutamyl
cysteinyl ligase (GCL) and cysteine availability [8]; ex-
pression of the rate limiting GCL enzyme is coupled to
cellular redox state through the Nrf-2-KEAP1 system,ry Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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tive stress through de novo GSH biosynthesis [8].
Therefore a decrease in protein thiols e.g. through oxi-
dation should give rise to an increase in de novo GSH
synthesis so that cellular redox state is restored.
T cell protein-thiol oxidation may arise from many
processes including; 1) an increase in reactive oxygen/
nitrogen species production; 2) lack of free thiols on
amino acids, peptides and small proteins which serve a
scavenging function e.g. cysteine, GSH and thioredoxin;
and 3) inefficient enzymic reduction of oxidised thio-
redoxin or GSSG back to reduced thioredoxin and
GSH. These latter processes are normally catalysed by
thioredoxin and glutathione reductases which require
NADPH as a cofactor [9].
An increase in intracellular oxidised GSSG can
normally be minimised by promoting its efflux via
multidrug resistance-associated proteins [10]. In ad-
dition, organelles such as the mitochondrion (which also
express thioredoxin 2 uniquely) and the nucleus main-
tain active transport processes for GSH to preserve a
local reducing environment against concentration gra-
dients as required for cell proliferation, active gene
transcription and to minimise damage from reactive
oxygen species (ROS) leakage during respiration [9,10].
The efficiency of cytosolic thioredoxin 1 (Trx-1) is likely
to be of particular significance during chronic inflam-
mation when ROS/reactive nitrogen species (RNS)
production by phagocytes will favour a more oxidising
extracellular environment [11].
Trx-1 is a small, 12-kDa, conserved and ubiquitous
multifunctional protein with several redox-active cysteine
residues. It acts as an antioxidant, anti-inflammatory agent
and redox-regulating enzyme (reduces disulphide bonds
and sulphenic acids but also uniquely to Trx-1, has
transnitrosylation activity) [12-15]. Trx-1 regulates che-
mokine activity, reduces inflammation, cellular infiltration,
and lipopolysaccharide (LPS)-induced oxidative damage.
Trx-1 has many interaction partners depending on its
cellular localization. The most energetically and physiolo-
gically favourable reaction for Trx-1 is to reduce oxidised
peroxiredoxins within the redox network [16]. Through
its reductase activity it may regulate apoptosis, cell
growth, differentiation, migration, angiogenesis, tumori-
genesis, and development [17,18]. In the nucleus, Trx-1
binds directly to different transcription factors and thereby
modulates their DNA-binding activity, eg, p53, nuclear
factor-κB, and AP1 [19,20]. With respect to apoptosis
inhibition, at least three binding partners have been iden-
tified in the cytoplasm; the apoptosis signaling kinase 1,
the thioredoxin-interacting protein and actin, where actin
protects Trx-1 from degradation and preserves its anti-
apoptotic function [17,21]. Trx-1 also associates with the
plasma membrane; it is trafficked with a limited numberof cytosolic proteins via the leaderless secretory pathway,
with anchorage in the membrane probably mediated by
palmitoylation of cysteine [22]. Trx-1 may also be se-
creted, exerting a range of effects on T cells, B cells and
fibroblasts from growth arrest to autocrine activation of
T cells [23]; extracellular Trx-1 influences the redox state
and function of ligands such as interleukin (IL)-4 [24] and
maybe taken up by adjacent cells via lipid rafts when
cysteine is oxidised [25]. The post-translational modifica-
tions to cysteine on Trx-1 appear critical to its localisation
and function in a range of cells.
Normally, the ageing immune system is characterised by
an inflammatory phenotype, increased risk for autoim-
munity and reduced antigen-specific immune responses, a
phenomenon referred to as ‘immunosenescence’. Typical
dysfunction in immune responses related to cellular
dysregulation, include impaired phagocytosis by neutro-
phils [26] and in T cells, reduced levels of TCR/CD28
receptor expression due to transcriptional inactivation [27]
and skewing of immune effector pathways by persistent
pathogens such as cytomegalovirus (CMV) that stimulate
futile clonal expansion and senescence [28]. Consequently,
ageing T cells are considered to be hyporesponsive to
stimulus and refractory to apoptosis, a phenomenon that
we have previously associated with altered redox state [11].
We have previously reported that loss in intracellular
GSH during hypoxia enhanced T cell interleukin 2 re-
ceptor expression in response to phytohaemagglutinin
(PHA) and that cytotoxic effects of methotrexate were
decreased [29]. Using plumbagin, a thiol depleting agent
that increases cytosolic ROS, mitogen-induced T-cell
proliferation and cytokines (interleukin (IL)-2/IL-4/IL-6/
interferon-gamma) production was suppressed and this
effect was reversed by thiol antioxidants but not by non-
thiol antioxidants [30]. Buthionine sulfoximine (BSO),
an inhibitor of GSH synthesis, markedly reduced T cell
proliferation without affecting viability and blocked pro-
duction of IL-2 and IL-6 [31]. In contrast, others have
shown that BSO could not inhibit IL-2 production i.e.
lymphocyte activation but did inhibit cell cycle entry and
proliferation [32,33]. Indeed exogenous GSH has been
shown to inhibit IL-2 synthesis in mitogenically stimu-
lated T cells although was required for DNA synthesis
by Roth and Droge [34], but in contrast exogenous GSH
decreases IL-4 but not IL-2 production in peripheral
blood lymphocytes [35].
Here we have investigated whether ageing affects the
exofacial distribution of Trx-1 on T cells, its secretion
into the plasma or cell culture media and whether this
change is brought about by the anticipated change in
redox state observed in ageing. Improved understanding
of any changes in expression or distribution of Trx-1
might improve our understanding of T cell responses
during ageing and may prove to be a useful biomarker of
A 
B 
yo
un
g
m
idl
ife
0.0
0.5
1.0
1.5
Figure 1 Older adults express lower surface and secrete less
Trx-1 than younger adults. (A) Peripheral blood was collected
from consenting volunteers (n = 6/group) into Optilyse prior to
staining with anti-Trx-1 or isotype control antibody on ice for
30mins and detection by goat-anti-mouse APC-Cy7 conjugate. Data
are expressed as the difference in MdX between antigen specific
and isotype control signal over 5000 events. (B) Plasma Trx-1 was
measured competitive inhibition ELISA. Data represents the
mean +/− SEM where * represents p < 0.05 by unpaired t test with
Welch’s correction for unequal variances.
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soluble plasma Trx-1 levels are decreased during healthy
ageing and decreased on Jurkat T cells after inhibition of
glutathione synthesis.
Results
Trx-1 is a small protein with antioxidant and regulatory
functions which is present at high concentrations intra-
cellularly. It works in concert with other antioxidant
enzymes and NADPH as a reducing agent to maintain
cellular redox status, and it is involved in the regulation
of redox signalling. It is considered pivotal for growth
promotion, inflammatory modulation and has anti-
apoptotic activity. Regulation of these physiological path-
ways declines with age and therefore we have explored
the whether immune cell Trx-1 is modulated by ageing.
Using flow cytometry we have shown that peripheral
blood lymphocytes from older adults (>50 years of age)
expressed less surface Trx-1 than the lymphocytes of
younger adults (mean age = 26.2 years); Figure 1A. When
we permeabilised primary cells with triton x-100 after
fixation, the levels of Trx-1 detected were significantly
higher than in non-permeabilised cells and there were
no differences between individuals according to age
(data not shown). Moreover, secreted levels of Trx in the
plasma were also significantly lower in older adults
(Figure 1B). In order to investigate whether cellular
redox stress drives a cellular adaptation in Trx-1 distri-
bution, we used the GCL inhibitor, BSO, to deplete
intracellular GSH without affecting viability in Jurkat T
cells. T cell GSH was determined by the 5,5′-dithiobis-
(2-nitrobenzoic acid) (DTNB) recycling assay after BSO
treatment for 24 and 48 hours. Figure 2A confirms that
intracellular GSH is depleted after 24 hour incubation
with BSO in a dose dependent manner. Moreover, cell
viability was unaffected by this treatment (Figure 2B)
despite a 50% reduction in the concentration of reduced
to oxidised GSH (Figure 2C). There was a slight but sig-
nificant increase in intracellular peroxides associated
with BSO treatment as determined by a 30% increase in
dichlorofluorescein acetate fluorescence (DCF) after
24 hours (Figure 2D).
During cell ageing and under stress, secretion of cyto-
plasmic proteins via the leaderless secretory pathway is
altered. We used a biotin capture technique based on
reaction with free amines to selectively purify membrane
proteins to determine whether redox stress also exerted
any effect on the translocation to the membrane and sub-
sequent association with the extracellular face. Figure 3
illustrates that biotinylation is restricted to the surface of
T cells and that streptavidin purification will capture
exofacial proteins. Given that Trx-1 has been previously
been described as being associated with the membrane of
T cells, we investigated whether its association with themembrane is changed under oxidative stress and we
studied T cell membrane Trx-1 after BSO treatment.
Figure 4 illustrates that membrane-associated Trx-1 levels
are lower after GSH depletion whereas CD3 expression
remains unchanged.
To explore whether the depletion in surface Trx-1
with BSO treatment could be attributed to an increased
rate of shedding or secretion of the protein, soluble
Trx-1 was measured in the supernatant after 24 h incu-
bation with BSO. Secreted Trx-1 levels were also signi-
ficantly reduced by BSO treatment (Figure 5A). Despite
the loss of surface and secreted Trx, there was only a
small non-significant loss of cell surface thiols in the
presence of BSO (Figure 5B). To investigate the
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Figure 2 Buthionine sulfoximine (BSO) depletes Jurkat T cell of
GSH. Jurkat T cells treated with BSO for 24 hours were depleted of
intracellular glutathione as determined by the GSH recycling assay
(A). This was not associated with any loss in viability determined by
trypan blue exclusion (B). The redox ratio of reduced to oxidised
GSH was decreased by 50% after incubation with 25 μM BSO for
24 hours (C). The effect of BSO treatment on intracellular ROS was
determined as DCF fluorescence after incubation with 25 μM BSO
for 24 hours (D). Data represents the mean +/− SEM of three
experiments where * represents p < 0.05.
Figure 3 Membrane proteins can be selectively purified from T
cells by biotin capture. Jurkat T cells were labelled NHS-S-S-biotin
linker and stained with streptavidin alexafluor488. Labelling is
evident on the surface of the cell only.
Figure 4 Trx-1 distribution to the membrane is impaired by
buthionine sulfoximine (BSO). Biotinylated plasma membrane
surface proteins from Jurkat T cells without (C, CON) and with (BSO)
glutathione depletion, were purified by streptavidin beads and
characterised using antibodies to detect plasma membrane (CD3)
and cytosol (lactate dehydrogenase, LDH) proteins and
thioredoxin (Trx-1).
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tathione loss and the loss of extracellular Trx-1 we used
diethyl maleate, which conjugates and depletes GSH but
does not affect its synthesis, and a global protein syn-
thesis inhibitor cycloheximide (CHM) at non-toxicconcentrations. In common with BSO, these agents also
depleted intracellular GSH, reduced the extent of Trx-1
secretion and had no effect on extracellular thiol content
(Figures 5C-E).
Others have shown previously that a thiol depleting
agent (plumbagin) results in increased mitogen-induced
T-cell proliferation but that cytokine (IL-2/IL-4/IL-6/
IFN-gamma) production was suppressed. To investigate
whether loss of cellular GSH specifically rather than
thiols generally is an important target for altering cyto-
kine secretion profile, we evaluated IL-2 production in
Jurkat T cells in the presence of BSO. Figure 6 confirms
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Figure 5 Jurkat T cell Trx-1 secretion is reduced but surface thiol levels remain unchanged after intracellular glutathione depletion.
(A) Trx-1 secreted into the media over a 24 hour treatment with BSO (25 μM) was analysed by competition ELISA. (B) Surface thiols were
analysed on Jurkat T cells after treatment with BSO (25 μM for 24 hours) using FITC-conjugated maleimide and analysed by flow cytometry.
(C) Compared with buthionine sulfoximine treatment (BSO; 25 μM; 48 hours), diethylmaleate (DEM; 20 μM; 48 hours) and cycloheximide (CHM;
0.1 μg/ml; 48 hours) also depleted intracellular glutathione as determined by the DTNB recycling assay. Intracellular GSH loss was associated with
a decrease in Trx-1 secretion determined by competition ELISA (D) but surface thiols analysed bby FITC-maleimide labelling and flow cytometry
remained unaffected (E). Data represents the mean +/− SEM where * represents p < 0.05 by unpaired t test with Welch’s correction for unequal
variances or # represents p < 0.05, ## p < 0.01 and ### p < 0.001 by ANOVA.
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to PHA when GSH is depleted.
Discussion
We have investigated surface Trx-1 in peripheral blood
lymphocytes from healthy adults of different ages and
observed that older adults express lower surface Trx-1
and secrete less Trx-1 into their plasma. However, therewas no difference between young and older adult total
(intra- and exofacial) expression of Trx-1.
Some cytosolic proteins are exported via a non-
canonical leaderless sequence secretory pathway which
can be p53 dependent [36,37]. Moreover, a major hall-
mark of cellular senescence is induction of the senescent
phenotype which is characterized by secretion of pro-
inflammatory factors; thus the condition has been called
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Figure 6 Glutathione (GSH) depletion by buthionine
sulfoximine (BSO) impairs IL-2 secretion from Jurkat T cells.
Depletion of intracellular GSH in Jurkat T cells by treated with 100 μM
BSO for 24 hours reduces phytohaemaglutinin (PHA; 1 μg/ml; 24 and
48 hours) induced secretion of IL-2. Data are mean+/− SEM from three
experiments, where * represents p < 0.05.
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Given the close redox relationship between intracellular
GSH and Trx-1 [9] which is transported through this
non-canonical leaderless sequence secretory pathway, we
have investigated whether GSH depletion influences
Trx-1 localisation at the membrane.
Our present study demonstrates that a change in
concentration of the major intracellular redox buffer,
GSH, influences the expression of a specific redox active
protein on the T cell surface, Trx-1, its secretion into the
extracellular media and the response to mitogen as mea-
sured by export of IL-2; there is less Trx-1 associated
with the membrane and less in the extracellular space
when intracellular GSH levels are depleted. However, in
considering global surface thiols on BSO-treated cells we
observed that these were not affected by BSO, DEM or
CHM treatment in cell culture. These findings suggest
either that the stress of cell culture exceeds the redox
stress applied, that all the readily oxidisable thiols exist
in an oxidised form in culture or that other processes
unaffected by intracellular GSH depletion maintain the
surface thiol redox state.
We have shown here that Trx-1 secretion is decreased
rather than increased and that total expression of Trx-1
does not appear to be decreased based on equivalent
levels total Trx-1 analysed in permeabilised cells. How-
ever, it is not clear whether its rate of degradation is
increased or if trafficking is affected. Others have shown
that Trx-1 on the T cell surface changes during chronic
disease and stress, and that the full length isoform is
anti-inflammatory but the 10 kDa truncated form is pro-
inflammatory [39-41]. The extracellular function of
Trx-1 is suggested to be as a reducing agent. Thisfunction is also shared with protein disulphide iso-
merase, the activity of which is important for HIV entry,
although target proteins may be discrete between the
two reducing proteins [42,43]. In either case, for the
enzymes to maintain their reducing activity, they require
a source of reducing agents and for Trx-1, the presence
of Trx-1 reductase [13]. During ageing when the extra-
cellular environment is more oxidising the potential to
regenerate the chemically reduced from of Trx-1 is likely
to be lower [1]. It remains to be determined whether any
proteins partner uniquely with Trx-1 and if their oxida-
tion state is altered during ageing or following intracel-
lular GSH depletion. Normally, human Tregs express
and secrete higher levels of Trx-1 than other T cells.
This may prevent uncontrolled immune reactions by
favouring survival of suppressor rather than effector cells
[5]. Whether the depletion of Trx-1 on T cells from
older adults may predispose to less suppression of the
immune response e.g. to CMV or autoantigens remains
to be explored [27,28].
The IL-2 secretory response to PHA follows from
lectin-mediated cross-linking of surface proteins into
large rafts and requires activation of either NFAT or
AP1 transcription factors in the nucleus, both of which
are redox dependent [44,45]. After translation, IL-2 is
processed for secretion through conventional secretory
pathways involving vesicular transport via the golgi. It is
unknown whether the effect of GSH loss on cytokine
responses observed here is most profound on IL-2
secretion or whether other cytokines are affected. How-
ever, the findings of lower response to PHA from BSO-
treated Jurkat T cells are consistent with the refractory
nature of older adult T cells to mitogenic stimuli which
associates with oxidative stress [11]. It is not anticipated
that redistribution of Trx-1 away from the surface of
cells to the cytoplasm per se will influence an extracel-
lular response directly although, it may play a more
important role in lipid raft organisation and receptor
clustering when internalised [46]. Instead, in the extra-
cellular space, its capacity to play a regulatory role
through catalysing the chemical reduction of receptors
or ligands may be impeded.
The importance of Trx-1 in ageing has been impli-
cated by studies that show embryonic lethality after
Trx-1 knockout but enhanced lifespan for Trx-1 trans-
genic animals [2,47]. These findings contrast with other
studies on mitochondrial Trx-2 which after overex-
pression, did not affect lifespan. We are now investiga-
ting the distribution of Trx-1 on mononuclear cells
during ageing as part of the MARKAGE study. If the
findings in our pilot study of healthy older adults and
observations with GSH-depleted Jurkat cells depleted
are upheld in primary cells, we will explore the role of
Trx and its oxidation state on the surface of ageing T
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between redox state and adaptation within and on the
surface of cells of ageing T cells merits investigation in
healthy ageing.
Conclusion
We have shown for the first time that the cellular dis-
tribution of Trx-1 on lymphocytes changes during healthy
ageing with lower secretory and exofacial Trx-1 expres-
sion. Moreover, depletion of intracellular glutathione can
recapitulate these effects in Jurkat T cells. Any direct
effects of Trx-1 redistribution for cellular function, inde-
pendent of GSH depletion, remain to be determined
within the context of ageing.
Experimental
Recruitment of participants
Young male adults (18–35 years old) and mid-life male
adults (50–70 years old) who were healthy, non-
smokers and were not taking any disease modifying or
anti-inflammatory medication or nutritional supple-
ments were recruited. Participants provided informed
written consent and ethical approval was obtained from
the Aston University Ethics Committee. After an over-
night fast, 5 mL whole blood was drawn from the
anticubital vein of each participant and collected into
ethylenediaminetetraacetic acid (EDTA) coated tubes
(Greiner Bio-One Ltd, UK) between 8:00 and 10:30 am.
Cell culture
Human Jurkat T cells from ATCC were maintained in
RPMI 1640 media containing 10% foetal bovine serum
and 200 U/ml penicillin and streptomycin at 37°C in a
humidified atmosphere of 5% CO2 and 95% air. Cells
were passaged at confluence and used between passages
20 and 30.
Intracellular glutathione determination (DTNB recycling
assay)
After 24 hours incubation with buthionine sulfoximine
(BSO), diethyl maleate (DEM) or cycloheximide (CHM),
treated cells and non-treated control T cells (5 × 105 cells)
were pelleted, washed twice with PBS and the pellet was
air dried for 5 min. Sulfosalicylic acid (SSA; 3.33 μl of 100%
made up in distilled water) was then added to the cell
pellet, vortexed and immediately centrifuged at 6600 × g
for 1.5 min. Stock buffer (96.6 μl of 125 mM sodium phos-
phate, 6.3 mM disodium EDTA, pH 7.5) was then added
to each tube, vortexed and re-centrifuged as above. Super-
natants were collected into fresh tubes and GSH and
GSSG levels were assessed by the GSR-DTNB recycling
assay on the same day or samples were immediately stored
at -80°C for analysis within one month [48]. Protein con-
centration was measured by bicinchoninic assay [49].Determination of intracellular ROS
Cells were loaded with 50 μM DCFH-DA per 2 × 106
cells for the final 40 minutes of BSO treatment [50].
Immediately following agent/DCFDA incubation, cells
were analysed by flow cytometry (EPICS® XL-MCL),
with the first control population always adjusted to the
third log decade, giving a MdX value of ~100. The viable
cell population, determined by FS and SS properties,
were gated to exclude debris, clumped cells or machine
noise. 10,000 cells were examined from each sample on
a histogram of log FL1 (DCF fluorescence) versus count.
Membrane protein preparation
Jurkat T cells (107/mL) were washed three times in ice
cold PBS (1 mL; pH 8) and cell surface proteins labeled
with 0.5 mg/mL biotin (EZ-Link™ Sulfo-NHS-SS-Biotin,
Thermo Scientific, UK) for 20 minutes at 4°C on a rotary
mixer according to Zhou et al. [51]. This reagent reacts
with amines and so its efficiency is not affected by the
treatments used here. It includes a disulfide bond in
spacer arm allows the biotin label to be removed using
reducing agents such as DTT and which prevents intra-
cellular protein capture due to the strongly reducing
environment of the cell.
Cells were lysed on ice for 30 minutes in MNE lysis
buffer (150 mM NaCl, 2 mM EDTA, 25 mM MES, 1 mM
Na3VO4, 1% Triton X-100 and 0.1% protease inhibitor
cocktail), sheared using a 21 G needle (Terumo, UK) and
centrifuged at 4,500 g for 5 minutes to obtain a post nu-
clear supernatant (PNS). Biotinylated membrane proteins
were extracted by binding to 200 μL of pre washed
Magnabind™ Streptavidin beads (Thermo Scientific, UK)
and eluted into extraction buffer (8 M Urea, 2 M
Thiourea, 2% w/v CHAPS and 1% destreak) for SDS-
PAGE analysis and Western blotting.
Confocal microscopy
Jurkat T cells were biotinylated as described above or left
unlabeled, washed three times with PBS and allowed to
adhere to poly-L-lysine coated microscope slides (VWR,
UK) for 20 minutes. Cells were subsequently fixed with
1% formaldehyde, 1% BSA in PBS at room temperature,
rinsed in PBS and incubated with a 1:1000 dilution of
2 mg/mL streptavidin-Alexa 488 (Life Technologies, UK)
for 30 minutes at 4°C. Cells were rinsed in PBS and
visualized using Leica Confocal Microscopy (Leica, UK).
Western blot for thioredoxin-1 (Trx-1)
For immunodetection of membrane-associated proteins,
15 μg of cell lysate in modified Laemmli buffer was
subjected to 10% SDS-PAGE, transferred onto PVDF
membrane, and blocked overnight with 3% w/v BSA in
Tris buffered saline supplemented with 0.05% Tween20
[48]. The membrane was probed with primary monoclonal
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room temperature followed by extensive washing then
incubated with horse radish peroxidase-labelled anti-
mouse IgG (1:20000) for 2 hours. The immunoreactive
bands were detected by enhanced chemiluminescence (GE
Healthcare, UK).
IL-2 analysis
After depletion of intracellular GSH for 24 hours by
treatment with BSO (100 μM) cells were washed twice
with PBS, resuspended in fresh culture media and stimu-
lated with 1 μg/ml PHA-L for 24 or 48 hours. Following
the cell stimulations cell culture media was collected
and cells were pelleted by centrifugation (200 g, 10mins),
cell free media containing secreted cytokines was stored
at −20°C until analysis for IL-2 by ELISA (Peprotech,
UK).
Cell surface thioredoxin by flow cytometry
For flow cytometric analysis of Trx-1, whole blood (50 μL)
was fixed by addition of 500 μL OptiLyse C (Beckman
Coulter) for 2 hours and then stored at −80°C prior to
analysis. Peripheral blood leukocytes were washed four
times in cold wash buffer (PBS supplemented with 1% w/v
BSA) and left on ice in blocking buffer (0.3 M glycine,
1% w/v BSA and 10% w/v goat serum (PAA) in PBS) for
30 minutes. Following two washes in cold wash buffer,
cells were incubated with mouse monoclonal anti-
thioredoxin (ab16965; AbCam) or IgG2b isotype control
antibody (ab91366; AbCam) on ice for 30 minutes. After
a further two washes, cells were incubated with goat
anti-mouse polyclonal conjugated APC-Cy7 (ab130791;
AbCam) antibody on ice for 30 minutes. Finally, cells
were washed twice in cold wash buffer and analysed on
a Cytomics FC 500 flow cytometer (Beckman Coulter,
Wycombe, UK).
Flow cytometric analysis of cell surface thiols
Jurkat cells (1 × 105) were treated with 10 μM maleimide
and Alexa Fluor® 488 C5 maleimide dye (Life Technolo-
gies, Carlsbad, CA) (to the ratio of 9:1) for 30 min. Cells
were washed with PBS three times and analysed free sur-
face thiol groups by flow cytometry (Beckman Coulter).
Thioredoxin competition ELISA
Trx-1 (2 μg/ml) 50 μl/well was applied to a Maxisorp
microtiter 96 well plates (Nunc) in carbonate buffer
pH9.6 and incubated for 1 hour at 37°C. Microtiter plate
wells were washed 3 times with 250 μl of phosphate
buffered saline containing 0.05% Tween-20, w/v (PBST)
and were gently tapped on absorbent tissue paper. Fol-
lowing washing, nonspecific sites were blocked by
adding Tween-20 1% v/v in PBS, 200 μl/well for over-
night at +4°C. Standard curve (5 μg/ml-0 ug/ml) wasprepared using human Trx-1 protein (ab51064; AbCam);
25 μl/well). Plasma samples or cell supernatants
(25 μl/well) were plated in triplicates. Mouse mo-
noclonal anti-hTRX-1 (25 μl of 0.5 μg/ml in PBS,
ab16965; AbCam) was added to all standards and
sample microtiter wells and plates were incubated at
37°C for 2 h. Following incubation, wells were washed
with PBST (250 μl) 3 times and 50 μl of peroxidase
conjugated anti-mouse antibody (0.2 μg/ml in PBS)
was added to each well. The plate was incubated at
37°C for 2 h. Following washing 3 times with PBST
(250 μl), and 200 μl of substrate solution containing
o-phenylenediamine and hydrogen peroxide in 0.15 M
citrate-phosphate buffer, was added. During incubation
at room temperature, colour development was ob-
served from 2 to 10 min. The colour reaction was
stopped with the addition of 2 M sulphuric acid
(50 μl/well). Absorbance was measured at 490 nm in a
microplate reader (Bio Tek, UK).
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